🔍 Search symptoms
Congenital Conditions

Schwannomatosis

Serious ICD-10: Q85 · NIH NLM
हिंदी: श्वानोमैटोसिस · தமிழ்: ஸ்க்வானோமடோசிஸ் · ಕನ್ನಡ: ಶ್ವಾನೋಮಟೋಸಿಸ್ · తెలుగు: ష్వానోమాటోసిస్ · বাংলা: শোয়ানোমাটোসিস · मराठी: श्वानोमॅटोसिस · ગુજરાતી: શ્વાનોમેટોસિસ
About this condition

Schwannomatosis is a rare genetic disorder causing multiple benign nerve tumors called schwannomas to grow throughout the body. Unlike other similar conditions, it primarily causes chronic pain rather than other neurological problems. Patients require long-term monitoring and pain management, though the tumors are typically non-cancerous.

Common symptoms
multiple skin lumps chronic pain numbness tingling muscle weakness tumors under skin
⚠️
When to see a doctor: within 1-2 weeks for evaluation; earlier if severe pain
Take action
This condition in Indian languages
Hindi (हिंदी)श्वानोमैटोसिस · तंत्रिका ट्यूमर रोग · नसों में गांठ · स्नायु रसौली
Tamil (தமிழ்)ஸ்க்வானோமடோசிஸ் · நரம்பு கட்டிகள் · நரம்பு கட்டி நோய் · ஸ்வான்னோமடோசிஸ்
Kannada (ಕನ್ನಡ)ಶ್ವಾನೋಮಟೋಸಿಸ್ · ನರ ಗೆಡ್ಡೆಗಳು · ಶ್ವಾನ್ ಕೋಶ ಗೆಡ್ಡೆ · ನರಗಳ ಗೆಡ್ಡೆ ರೋಗ
Telugu (తెలుగు)ష్వానోమాటోసిస్ · నాడి గడ్డలు · నరాల కణితులు · ష్వాన్ కణితుల వ్యాధి
Bengali (বাংলা)শোয়ানোমাটোসিস · স্নায়ু টিউমার রোগ · স্নায়ুতে গোটা · শোয়ান কোষ টিউমার
Marathi (मराठी)श्वानोमॅटोसिस · मज्जातंतू गाठी · मज्जातंतू ट्यूमर रोग · श्वान पेशी गाठी
Gujarati (ગુજરાતી)શ્વાનોમેટોસિસ · નર્વ ગાંઠો · ચેતા ગાંઠ રોગ · શ્વાન સેલ ગાંઠ
Frequently asked questions
What are the symptoms of Schwannomatosis?
multiple skin lumps, chronic pain, numbness, tingling, muscle weakness, tumors under skin.
When should I see a doctor?
within 1-2 weeks for evaluation; earlier if severe pain
Is Schwannomatosis common in India?
This condition is seen across India.
How serious is Schwannomatosis?
Severity is classified as Serious. within 1-2 weeks for evaluation; earlier if severe pain.
Related conditions
Important: This information is for general awareness only and is not a substitute for professional medical advice. Always consult a qualified doctor. In an emergency, call 112. Data sourced from NIH NLM and MOHFW India. Full disclaimer